Body temperature, not hexosamine pathway, controls global protein O-GlcNAcylation across mice, flies, fish and cells

The Finding

A recent study, whose authors and institution were not specified in the pre-print data from bioRxiv (published in 2026), reveals that core body temperature, rather than the availability of hexosamine biosynthetic pathway (HBP) precursor metabolites like N-acetylglucosamine (GlcNAc), is the master regulator of global protein O-GlcNAcylation. Utilizing a comparative experimental approach across Bcs1l mutant mice, *Drosophila* species, zebrafish, and cultured mammalian cells, the researchers observed a systemic loss of O-GlcNAc in hypothermic subjects. This loss strongly positively correlated with body temperature, while N-acetylglucosamine supplementation failed to restore O-GlcNAc levels.

How They Got There

The investigation began with Bcs1l mutant mice, a model exhibiting mitochondrial complex III deficiency and pronounced hypothermia, which also presented with a systemic reduction in protein O-GlcNAcylation. To disentangle the regulatory mechanisms, the team measured various factors. They found that while HBP precursor metabolites linked to mitochondrial function were decreased in the mutant liver, UDP-GlcNAc levels — the direct substrate for O-GlcNAcylation — remained largely unaffected across tissues and did not correlate with O-GlcNAc levels.

To test the role of the HBP, N-acetylglucosamine supplementation and overexpression of the HBP rate-limiting enzyme, GFPT1, were attempted. Neither intervention restored O-GlcNAc levels in the hypothermic mice. The researchers then focused on body temperature, successfully preventing O-GlcNAc loss in mutant mice by correcting hypothermia through liver-targeted gene therapy, expression of alternative oxidase (AOX), or controlled housing at 35°C. Further validation involved demonstrating that temperature similarly dictated O-GlcNAc status in poikilothermic organisms like *Drosophila* species and zebrafish, as well as in cultured mammalian cells. Proteome solubility profiling was also employed to assess the functional consequences of O-GlcNAcylation changes.

The Mechanism: What Happens Biologically

Protein O-GlcNAcylation is a dynamic post-translational modification involving the cycling of a single N-acetylglucosamine sugar onto serine and threonine residues of intracellular proteins. This process is precisely controlled by two enzymes: O-GlcNAc transferase (OGT) adds the sugar, and O-GlcNAcase (OGA) removes it. The study uncovered that temperature directly impacts this delicate balance.

In hypothermic conditions, cultured mammalian cells exhibited a transcriptional decrease in OGT expression and a corresponding increase in OGA expression. This altered OGT:OGA ratio provides a simple, direct regulatory mechanism explaining the temperature-dependent reduction in global O-GlcNAc levels. The researchers propose that this temperature-dictated O-GlcNAcylation serves an evolutionarily conserved role, protecting the proteome from temperature-induced structural fluctuations and maintaining interactome stability in both warm-blooded (homeothermic) and cold-blooded (poikilothermic) organisms.

Study Limitations

This research, published as a pre-print, is yet to undergo formal peer review, which is a standard part of scientific publication. The primary mammalian model involved Bcs1l mutant mice, which develop hypothermia due to a specific mitochondrial complex III deficiency; thus, the findings are directly observed in a disease model rather than healthy subjects. While the study effectively established a mechanistic link between temperature and O-GlcNAcylation, it also indicated that pharmacologically inhibiting OGA, which restored O-GlcNAc levels in hypothermic mice, did not affect disease progression. This suggests that the observed O-GlcNAc reduction might be a physiological consequence of hypothermia rather than a primary driver of the underlying pathology, complicating direct therapeutic applications.

Practical Application

This study provides fascinating mechanistic insights into how a fundamental physiological parameter — body temperature — governs protein O-GlcNAcylation, a critical post-translational modification. However, it is too early to apply these findings to a personal protocol for human performance optimization or longevity. The research is primarily conducted in animal models and cultured cells, and it identifies O-GlcNAc changes as a *consequence* of temperature shifts, not necessarily a primary target for intervention in healthy individuals.

Further research is needed, specifically human trials, to determine if targeted modulation of core body temperature influences O-GlcNAcylation in healthy adults and whether such changes translate into measurable benefits for human performance or resilience. Before any practical recommendations could emerge, larger-scale human studies would be necessary to establish both safety and efficacy, particularly considering that the study found N-acetylglucosamine supplementation did not restore O-GlcNAc levels under hypothermic conditions.

---

Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.